These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26882083)

  • 1. Associations between Single-Nucleotide Polymorphisms in Corticotropin-Releasing Hormone-Related Genes and Irritable Bowel Syndrome.
    Sasaki A; Sato N; Suzuki N; Kano M; Tanaka Y; Kanazawa M; Aoki M; Fukudo S
    PLoS One; 2016; 11(2):e0149322. PubMed ID: 26882083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone receptor 1 gene variants in irritable bowel syndrome.
    Sato N; Suzuki N; Sasaki A; Aizawa E; Obayashi T; Kanazawa M; Mizuno T; Kano M; Aoki M; Fukudo S
    PLoS One; 2012; 7(9):e42450. PubMed ID: 22957021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome.
    Komuro H; Sato N; Sasaki A; Suzuki N; Kano M; Tanaka Y; Yamaguchi-Kabata Y; Kanazawa M; Warita H; Aoki M; Fukudo S
    PLoS One; 2016; 11(1):e0147817. PubMed ID: 26808377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.
    Orand A; Naliboff B; Gadd M; Shih W; Ju T; Presson AP; Mayer EA; Chang L
    Psychoneuroendocrinology; 2016 Nov; 73():133-141. PubMed ID: 27497153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome.
    Tanaka Y; Kanazawa M; Kano M; Morishita J; Hamaguchi T; Van Oudenhove L; Ly HG; Dupont P; Tack J; Yamaguchi T; Yanai K; Tashiro M; Fukudo S
    PLoS One; 2016; 11(7):e0157347. PubMed ID: 27448273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome.
    Wouters MM; Lambrechts D; Knapp M; Cleynen I; Whorwell P; Agréus L; Dlugosz A; Schmidt PT; Halfvarson J; Simrén M; Ohlsson B; Karling P; Van Wanrooy S; Mondelaers S; Vermeire S; Lindberg G; Spiller R; Dukes G; D'Amato M; Boeckxstaens G
    Gut; 2014 Jul; 63(7):1103-11. PubMed ID: 24041540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
    Kano M; Muratsubaki T; Van Oudenhove L; Morishita J; Yoshizawa M; Kohno K; Yagihashi M; Tanaka Y; Mugikura S; Dupont P; Ly HG; Takase K; Kanazawa M; Fukudo S
    Sci Rep; 2017 Sep; 7(1):12425. PubMed ID: 28963545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome.
    Jiang Y; Nie Y; Li Y; Zhang L
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1186-91. PubMed ID: 24444427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 - A Randomized Clinical Trial.
    Khalighi Sikaroudi M; Mokhtare M; Janani L; Faghihi Kashani AH; Masoodi M; Agah S; Abbaspour N; Dehnad A; Shidfar F
    Complement Med Res; 2020; 27(5):302-309. PubMed ID: 32203968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroacupuncture in the treatment of IBS in rats: investigation of the mechanisms of CRH
    Gao F; Yuan WH; Wu SB; Wang ZB; Zhu GQ; Zhou MQ
    J Neurophysiol; 2023 Aug; 130(2):380-391. PubMed ID: 37435647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.
    Swan C; Duroudier NP; Campbell E; Zaitoun A; Hastings M; Dukes GE; Cox J; Kelly FM; Wilde J; Lennon MG; Neal KR; Whorwell PJ; Hall IP; Spiller RC
    Gut; 2013 Jul; 62(7):985-94. PubMed ID: 22684480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.
    Wong BS; Camilleri M; Carlson PJ; Guicciardi ME; Burton D; McKinzie S; Rao AS; Zinsmeister AR; Gores GJ
    Gastroenterology; 2011 Jun; 140(7):1934-42. PubMed ID: 21396369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of serotonin transporter SLC6A4 gene with Chinese Han irritable bowel syndrome.
    Yuan J; Kang C; Wang M; Wang Q; Li P; Liu H; Hou Y; Su P; Yang F; Wei Y; Yang J
    PLoS One; 2014; 9(1):e84414. PubMed ID: 24392134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome.
    Fukudo S; Nomura T; Hongo M
    Gut; 1998 Jun; 42(6):845-9. PubMed ID: 9691924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2A receptor gene polymorphisms and irritable bowel syndrome.
    Markoutsaki T; Karantanos T; Gazouli M; Anagnou NP; Karamanolis DG
    J Clin Gastroenterol; 2011 Jul; 45(6):514-7. PubMed ID: 21325954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-α gene -308 G > A and -238 G > A polymorphisms are associated with susceptibility to irritable bowel syndrome and drug efficacy in children.
    Sun MH; Sun LQ; Guo GL; Zhang S
    J Clin Pharm Ther; 2019 Apr; 44(2):180-187. PubMed ID: 30578560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress and visceral pain: focusing on irritable bowel syndrome.
    Fukudo S
    Pain; 2013 Dec; 154 Suppl 1():S63-S70. PubMed ID: 24021863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing hormone system polymorphisms are associated with children's cortisol reactivity.
    Sheikh HI; Kryski KR; Smith HJ; Hayden EP; Singh SM
    Neuroscience; 2013 Jan; 229():1-11. PubMed ID: 23131710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.